Asthma and allergies drug Singulair as generic version approved – Health Newstrack


Health Newstrack

Asthma and allergies drug Singulair as generic version approved
Health Newstrack
The U.S. Food and Drug Administration approved the first generic versions of Singulair (montelukast sodium) for use in adults and children to control asthma symptoms and to help relieve symptoms of indoor and outdoor allergies. Montelukast is in a
United States : FDA grants approval to TEVA to market generic asthma treatment Equities.com

all 2 news articles »

View full post on asthma – Google News